Company Filing History:
Years Active: 2021-2024
Title: Innovations of Ariel Wilson
Introduction
Ariel Wilson is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of cellular senescence and ocular health through his innovative patents. With a total of two patents to his name, Wilson's work focuses on advancing medical treatments and methodologies.
Latest Patents
Wilson's latest patents include compositions comprising SASP modulators and senescence attenuators. These compositions are designed for modulating cellular senescence and the induction of the senescence-associated secretory phenotype (SASP) in cells. The methods outlined in his patents involve modulating the level or activity of IRE1a to control cellular senescence and the SASP. Additionally, he has developed methods for treating and preventing ocular vascular diseases. This involves contacting cells in the eye with a biguanide compound and utilizing ophthalmic compositions that include this compound. Another significant patent describes a method for delivering exogenous biomolecules into the eye. This method includes injecting a mixture of exogenous biomolecules and plasmonic structures into the eye, followed by irradiating the area with a laser beam to form pores in the membranes of target cells, allowing for the delivery of biomolecules.
Career Highlights
Throughout his career, Ariel Wilson has worked with various organizations, including Rsem Limited Partnership and École Polytechnique. His experience in these institutions has contributed to his expertise in the field of biomedical innovations.
Collaborations
Wilson has collaborated with notable colleagues such as Przemyslaw Sapieha and Frédérick Antoine Mallette. These collaborations have further enhanced his research and development efforts in the medical field.
Conclusion
Ariel Wilson's contributions to the field of cellular senescence and ocular health through his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments and methodologies that can significantly impact patient care.